Literature DB >> 8406819

Arcanobacterium haemolyticum phospholipase D is genetically and functionally similar to Corynebacterium pseudotuberculosis phospholipase D.

W A Cuevas1, J G Songer.   

Abstract

Arcanobacterium haemolyticum, a pathogen of the human upper respiratory tract and other systems, has been reported to produce soluble toxins, including a phospholipase D (PLD). We confirmed production of PLD by this organism and cloned and sequenced pld. Arcanobacterial PLD (PLD-A) was found to be a protein of approximately 31.5 kDa with a pI of approximately 9.4. Cosmid cloning, followed by subcloning into phagemid pBluescriptIISK+, yielded Escherichia coli(pAh140), a recombinant with a gene product corresponding to PLD-A. Evidence of PLD activity was found by three assays in supernatant fluid of cultures of E. coli(pAh140) and A. haemolyticum, but not in E. coli(pBluescriptIISK+). Experiments to determine if this protein was secreted were not conducted, but previous work with PLD from Corynebacterium pseudotuberculosis suggested that the presence of the enzyme in culture supernatant fluids was due to lysis of E. coli rather than to active transport. Antibodies in polyclonal sera from goats immunized with native or recombinant PLD-A neutralized native and recombinant PLD-A activity, and antibodies against native or recombinant PLD from C. pseudotuberculosis (PLD-P) partially neutralized native and recombinant PLD-A. Antibodies prepared against recombinant PLD-A labelled both recombinant and native PLD-A in Western blots (immunoblots) and dot blots, but antibodies against PLD-P did not. Sequencing of the insert in pAh140 revealed an open reading frame of 930 bp coding for 309 amino acids, including a putative signal sequence of 26 amino acids (3.2 kDa, determined on the basis of homology with the 24-amino-acid signal sequence of pld from C. pseudotuberculosis bv. ovis) and the mature PLD protein (31.5 kDa). Sequence comparisons of coding regions revealed 65% DNA homology with pld genes from C. pseudotuberculosis and Corynebacterium ulcerans. Comparison of amino acid sequences revealed 64% homology of PLD-A both with PLD-P and with PLD produced by C. ulcerans.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8406819      PMCID: PMC281159          DOI: 10.1128/iai.61.10.4310-4316.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  The laboratory recognition of Corynebacterium hemolyticum.

Authors:  G J HERMANN
Journal:  Am J Med Technol       Date:  1961 Jan-Feb

2.  Observations on the biological properties of atypical haemolytic Corynebacteria isolated from man as compared with Cor, haemolyticum, Cor. Pyogenes bovis and Cor. ovis. I. In vivo investigations.

Authors:  F PATOCKA; M MARA; A SOUCEK; A SOUCKOVA
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1962

3.  Purification of the phospholipase D of Corynebacterium pseudotuberculosis by recycling isoelectric focusing.

Authors:  N B Egen; W A Cuevas; P J McNamara; D W Sammons; R Humphreys; J G Songer
Journal:  Am J Vet Res       Date:  1989-08       Impact factor: 1.156

4.  Corynebacterium hemolyticum and pharyngitis.

Authors:  B E Robinson; D L Murray
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

5.  Biochemical and genetic characterization of Corynebacterium pseudotuberculosis.

Authors:  J G Songer; K Beckenbach; M M Marshall; G B Olson; L Kelley
Journal:  Am J Vet Res       Date:  1988-02       Impact factor: 1.156

6.  Effects of alpha and theta toxins from Clostridium perfringens on human polymorphonuclear leukocytes.

Authors:  D L Stevens; J Mitten; C Henry
Journal:  J Infect Dis       Date:  1987-08       Impact factor: 5.226

7.  Cloning and expression of the phospholipase D gene from Corynebacterium pseudotuberculosis in Escherichia coli.

Authors:  J G Songer; S J Libby; J J Iandolo; W A Cuevas
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

8.  Cloning, nucleotide sequence, and expression in Escherichia coli of the phospholipase D gene from Corynebacterium pseudotuberculosis.

Authors:  A L Hodgson; P Bird; I T Nisbet
Journal:  J Bacteriol       Date:  1990-03       Impact factor: 3.490

9.  Rational attenuation of Corynebacterium pseudotuberculosis: potential cheesy gland vaccine and live delivery vehicle.

Authors:  A L Hodgson; J Krywult; L A Corner; J S Rothel; A J Radford
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

10.  Mutations in the hemolytic-phospholipase C operon result in decreased virulence of Pseudomonas aeruginosa PAO1 grown under phosphate-limiting conditions.

Authors:  R M Ostroff; B Wretlind; M L Vasil
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

View more
  10 in total

Review 1.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

2.  Arcanobacterium haemolyticum Utilizes Both Phospholipase D and Arcanolysin To Mediate Its Uptake into Nonphagocytic Cells.

Authors:  Patrick S Gellings; David J McGee
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

Review 3.  Clinical microbiology of coryneform bacteria.

Authors:  G Funke; A von Graevenitz; J E Clarridge; K A Bernard
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

4.  Mechanism of induction of complement susceptibility of erythrocytes by spider and bacterial sphingomyelinases.

Authors:  Denise V Tambourgi; Marcelo De Sousa Da Silva; Stephen J Billington; Rute M Gonçalves De Andrade; Fábio C Magnoli; J Glenn Songer; Carmen W Van Den Berg
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

5.  Phospholipase D promotes Arcanobacterium haemolyticum adhesion via lipid raft remodeling and host cell death following bacterial invasion.

Authors:  Erynn A Lucas; Stephen J Billington; Petteri Carlson; David J McGee; B Helen Jost
Journal:  BMC Microbiol       Date:  2010-10-25       Impact factor: 3.605

6.  Phenotypic and genotypic characterization of Arcanobacterium haemolyticum isolates from infections of horses.

Authors:  Abdulwahed Ahmed Hassan; Hivda Ulbegi-Mohyla; Talah Kanbar; Jörg Alber; Christoph Lämmler; Amir Abdulmawjood; Michael Zschöck; Reinhard Weiss
Journal:  J Clin Microbiol       Date:  2008-11-19       Impact factor: 5.948

7.  Arcanolysin is a cholesterol-dependent cytolysin of the human pathogen Arcanobacterium haemolyticum.

Authors:  B Helen Jost; Erynn A Lucas; Stephen J Billington; Adam J Ratner; David J McGee
Journal:  BMC Microbiol       Date:  2011-10-26       Impact factor: 3.605

Review 8.  Rhodococcus equi and Arcanobacterium haemolyticum: two "coryneform" bacteria increasingly recognized as agents of human infection.

Authors:  R Linder
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

9.  Evolutionary dynamics of origin and loss in the deep history of phospholipase D toxin genes.

Authors:  Matthew H J Cordes; Greta J Binford
Journal:  BMC Evol Biol       Date:  2018-12-18       Impact factor: 3.260

10.  Sphingomyelinase D Activity in Sicarius tropicus Venom: Toxic Potential and Clues to the Evolution of SMases D in the Sicariidae Family.

Authors:  Priscila Hess Lopes; Caroline Sayuri Fukushima; Rosana Shoji; Rogério Bertani; Denise V Tambourgi
Journal:  Toxins (Basel)       Date:  2021-04-01       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.